Lv4
448 积分 2025-01-20 加入
Overexpression and activation of the RON receptor tyrosine kinase in a panel of human colorectal carcinoma cell lines
7小时前
已完结
Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors
7小时前
已完结
Spatiotemporal Quantification of HER2-targeting Antibody–Drug Conjugate Bystander Activity and Enhancement of Solid Tumor Penetration
6天前
已完结
Improved Lysosomal Trafficking Can Modulate the Potency of Antibody Drug Conjugates
6天前
已完结
Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC
6天前
已完结
Adagrasib in Non–Small-Cell Lung Cancer Harboring a KRAS G12C Mutation
13天前
已完结
Sotorasib for Lung Cancers with KRAS p.G12C Mutation
13天前
已完结
Adaptive Feedback Signaling Through the FAK/SRC Pathway Promotes KRAS G12C Inhibitor Resistance
15天前
已关闭
Epithelial-to-Mesenchymal Transition is a Cause of Both Intrinsic and Acquired Resistance to KRAS G12C Inhibitor in KRAS G12C–Mutant Non–Small Cell Lung Cancer
16天前
已完结
Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer
16天前
已完结